The effect of plasma drug concentrations on HIV-1 clearance rate during quadruple drug therapyHOETELMANS, R. M. W; REIJERS, M. H. E; SCHUITEMAKER, H et al.AIDS (London). 1998, Vol 12, Num 11, pp F111-F115, issn 0269-9370Article

Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) studyREIJERS, M. H. E; WEVERLING, G. J; SCHUITEMAKER, H et al.Lancet (British edition). 1998, Vol 352, Num 9123, pp 185-190, issn 0140-6736Article

Toxicity and drug exposure in a quadruple drug regimen in HIV-1 infected patients participating in the ADAM studyREIJERS, M. H. E; WEIGEL, H. M; HART, A. A. M et al.AIDS (London). 2000, Vol 14, Num 1, pp 59-68, issn 0269-9370Article

Lack of thermal enhancement for taxanes in vitroRIETBROEK, R. C; KATSCHINSKI, D. M; REIJERS, M. H. E et al.International journal of hyperthermia. 1997, Vol 13, Num 5, pp 525-533, issn 0265-6736Article

Short report : evaluation of helicobacter pylori eradication with bismuth sucralfateREIJERS, M. H. E; NOACH, L. A; TYTGAT, G. N. J et al.Alimentary pharmacology & therapeutics. 1994, Vol 8, Num 3, pp 351-352, issn 0269-2813Article